Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (7280)	12/11/1999 2:09:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 9719

>> We don't even need to think too much about the co-existence issue. << Wasn't suggesting that we needed to so such, but was suggesting that it will still be wise. That is.... bex plus less flu tox equals better, but C2B8 plus less flu tox might not be as good as bex plus less flu tox. Is it likely that the characterisitics of a murine MAb, long considered as deficiencies, can be harnessed to provide superior therapy for given indications? >> come up with some kind of non-laughable hypothesis. << Hey! - g -